ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994

Radiologists Dispute Holland On NMR

April 20, 1984

NCAB Committee Still Debating How To Encourage Surgical Oncology

April 26, 1985

White House Order Poses Difficulties For NIH Peer Review

April 2, 1993

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007